Blog

In the world of drug development, the journey from promising molecule to approved medication is fraught with challenges. Nowhere is this more evident than in the field of cardiovascular medicine, where, despite significant unmet medical needs, the number of new drugs entering late-stage clinical trials has been declining.

The Funding Gap: Cardiovascular Drug Development

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

The Importance of Transparency and Trust in Clinical Trials:
In the complex world of clinical research, the relationship between sponsors, contract research organisations (CROs), and healthcare professionals (HCPs) is crucial. Yet, this relationship is often strained by an overwhelming burden of paperwork and administrative tasks that contribute to burnout among HCPs.

Building Bridges, Not Barriers in Clinical Studies

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

"While the road may be bumpy, it is also filled with valuable lessons that shape who we become." Matthew's view on Medical Research studies

Navigating the Bumps on the Road: Clinical Study Insights

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Clinical trials are the cornerstone of medical innovation, but not all trials are created equal. Understanding the nuances between different trial types, particularly between Clinical Study for Medical Device and pharmaceutical studies, is crucial for ensuring their success. This podcast explores these differences and highlights key considerations for optimising trial outcomes.

The Nuances of Clinical Trial Types & Medical Device Trials

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Clinical trials are vital for medical advancement, but a major challenge is non-enrolling sites—locations that are activated yet fail to enrol participants. This delays important research and incurs significant costs. We will examine the impact of these non-enrolling sites and discuss strategies to address the issue.

The Costs of Non-Enrolling Sites in Clinical Trials: A Deep Dive

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Lastest articles

The Funding Gap: Cardiovascular Drug Development

Building Bridges, Not Barriers in Clinical Studies

Navigating the Bumps on the Road: Clinical Study Insights

The Nuances of Clinical Trial Types & Medical Device Trials

The Costs of Non-Enrolling Sites in Clinical Trials: A Deep Dive